Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announced today a distribution partnership to ...

Akadeum's microbubble-based cell isolation workflow addresses critical bottlenecks in cell therapy manufacturing by providing a scalable, gentle, and fully closed GMP solution for cell separation.

Bracco’s cell selection and activation microbubble technology is designed to support both positive- and negative-selection strategies.

Akadeum has been successfully customer-audited per US and EU GMP standards, and the products meet endotoxin, sterility, and viral requirements per USP and ICH standards. As expected for raw materials ...

Researchers developed a microfluidic method that combines electric-field-driven flow and viscoelastic forces to improve ...

Researchers have unveiled a microfluidic device that significantly improves the separation of tumor cells and clusters from malignant effusions. This novel technology promises to advance the diagnosis ...

ANN ARBOR, Mich., June 3, 2025 /PRNewswire/ -- Akadeum Life Sciences, a pioneer in buoyancy-based cell separation technology, today announced the successful close of a $20 million+ financing round.

Press ReleaseIB Communicationsbracco@ibcomms.agency Bracco Enters Cell Therapy Manufacturing with Cell Selection and Activation TechnologiesTechnology based on Bracco’s clinically validated ...

Bracco Imaging is expanding into the cell therapy space to explore new applications of its long-established microbubble technology.